SPHK1 and metastatic colorectal cancer: Thus, in this study, the two SPs, SPK1 and its derivative SPKM19, were employed for the secretion of two therapeutic KRAS mimotopes, 68V-DT and wild-type KRAS, in developing L. lactis as a potential mucosal vaccine against metastatic colorectal cancer.